Rxivist logo

Rxivist combines preprints from bioRxiv with data from Twitter to help you find the papers being discussed in your field. Currently indexing 62,660 bioRxiv papers from 278,042 authors.

Comparing cancer cell lines and tumor samples by genomic profiles

By Rileen Sinha, Nikolaus Schultz, Chris Sander

Posted 02 Oct 2015
bioRxiv DOI: 10.1101/028159

Cancer cell lines are often used in laboratory experiments as models of tumors, although they can have substantially different genetic and epigenetic profiles compared to tumors. We have developed a general computational method, TumorComparer, to systematically quantify similarities and differences between tumor material when detailed genetic and molecular profiles are available. The comparisons can be flexibly tailored to a particular biological question by placing a higher weight on functional alterations of interest (weighted similarity). In a first pan-cancer application, we have compared 260 cell lines from the Cancer Cell Line Encyclopaedia (CCLE) and 1914 tumors of six different cancer types from The Cancer Genome Atlas (TCGA), using weights to emphasize genomic alterations that frequently recur in tumors. We report the potential suitability of particular cell lines as tumor models and identify apparently unsuitable outlier cell lines, some of which are in wide use, for each of the six cancer types. In future, this weighted similarity method may be generalized for use in a clinical setting to compare patient profiles consisting of genomic patterns combined with clinical attributes, such as diagnosis, treatment and response to therapy.

Download data

  • Downloaded 5,436 times
  • Download rankings, all-time:
    • Site-wide: 348 out of 62,660
    • In cancer biology: 10 out of 2,059
  • Year to date:
    • Site-wide: 2,123 out of 62,660
  • Since beginning of last month:
    • Site-wide: 4,312 out of 62,660

Altmetric data


Downloads over time

Distribution of downloads per paper, site-wide


Sign up for the Rxivist weekly newsletter! (Click here for more details.)


News